155 related articles for article (PubMed ID: 31240304)
1. Validated Liquid Chromatographic Method for the Determination of (Canagliflozin, Dapagliflozin or Empagliflozin) and Metformin in the Presence of (1-Cyanoguanidine).
Hassib ST; Taha EA; Elkady EF; Barakat GH
J Chromatogr Sci; 2019 Aug; 57(8):697-707. PubMed ID: 31240304
[TBL] [Abstract][Full Text] [Related]
2. Application of experimental design in HPLC method optimization and robustness for the simultaneous determination of canagliflozin, empagliflozin, linagliptin, and metformin in tablet.
Moussa BA; Mahrouse MA; Fawzy MG
Biomed Chromatogr; 2021 Oct; 35(10):e5155. PubMed ID: 33949720
[TBL] [Abstract][Full Text] [Related]
3. LC-MS/MS Determination of Empagliflozin and Metformin.
Ayoub BM; Mowaka S
J Chromatogr Sci; 2017 Aug; 55(7):742-747. PubMed ID: 28383657
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Determination of Metformin, Glipizide, Repaglinide, and Glimepiride or Metformin and Pioglitazone by a Validated LC Method: Application in the Presence of Metformin Impurity (1-Cyanoguanidine).
El-Zaher AA; Elkady EF; Elwy HM; Saleh MA
J AOAC Int; 2016 Jul; 99(4):957-963. PubMed ID: 27214744
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of Spectrophotometric Methods for the Determination of Canagliflozin or Gliclazide and Metformin in the Presence of Metformin Impurity (1-Cyanoguanidine).
Hassib ST; Taha EA; Elkady EF; Barakat GH
J AOAC Int; 2019 Jul; 102(4):1112-1124. PubMed ID: 30658719
[No Abstract] [Full Text] [Related]
6. Simple, fast and robust LC-MS/MS method for the simultaneous quantification of canagliflozin, dapagliflozin and empagliflozin in human plasma and urine.
van der Aart-van der Beek AB; Wessels AMA; Heerspink HJL; Touw DJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122257. PubMed ID: 32663790
[TBL] [Abstract][Full Text] [Related]
7. Valuation of environmental influence of recently invented high-performance liquid chromatographic method for hypoglycemic mixtures of gliflozins and metformin in the presence of melamine impurities: Application of molecular modeling simulation approach.
Fawzy MG; Said MA
J Sep Sci; 2023 Oct; 46(19):e2300267. PubMed ID: 37485588
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of an analytical method for metformin hydrochloride and its related compound (1-cyanoguanidine) in tablet formulations by HPLC-UV.
Al-Rimawi F
Talanta; 2009 Oct; 79(5):1368-71. PubMed ID: 19635372
[TBL] [Abstract][Full Text] [Related]
9. A new HPLC-MS/MS method for the simultaneous quantification of SGLT2 inhibitors and metformin in plasma and its application to a pharmacokinetic study in healthy volunteers.
Dias BCL; Fachi MM; de Campos ML; Degaut FLD; Peccinini RG; Pontarolo R
Biomed Chromatogr; 2019 Nov; 33(11):e4663. PubMed ID: 31339572
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatographic and spectrofluorimetric assays of empagliflozin: Applied to degradation kinetic study and content uniformity testing.
Abdel-Ghany MF; Ayad MF; Tadros MM
Luminescence; 2018 Aug; 33(5):919-932. PubMed ID: 29737023
[TBL] [Abstract][Full Text] [Related]
11. Challenges in simultaneous extraction and chromatographic separation of metformin and three SGLT-2 inhibitors in human plasma using LC-MS/MS.
Shah PA; Shrivastav PS; Sharma V; Yadav MS
J Pharm Biomed Anal; 2019 Oct; 175():112790. PubMed ID: 31362250
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the costs of glycemic response with canagliflozin versus dapagliflozin and empagliflozin as add-on to metformin in patients with type 2 diabetes mellitus in the United Arab Emirates.
Schubert A; Buchholt AT; El Khoury AC; Kamal A; Taieb V
Curr Med Res Opin; 2017 Jun; 33(6):1155-1163. PubMed ID: 28323512
[TBL] [Abstract][Full Text] [Related]
13. Stability-indicating ultra performance liquid chromatography method development and validation for simultaneous estimation of metformin, linagliptin, and empagliflozin in bulk and pharmaceutical dosage form.
Vankalapati KR; Alegete P; Boodida S
Biomed Chromatogr; 2021 Apr; 35(4):e5019. PubMed ID: 33146442
[TBL] [Abstract][Full Text] [Related]
14. Empagliflozin: HPLC based analytical method development and application to pharmaceutical raw material and dosage form.
M Hanif A; Bushra R; Ismail NE; Bano R; Abedin S; Alam S; Ahmed Khan M; Muhammad Arif H
Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1081-1087. PubMed ID: 34602436
[TBL] [Abstract][Full Text] [Related]
15. Liquid chromatographic determination of sitagliptin either alone or in ternary mixture with metformin and sitagliptin degradation product.
El-Bagary RI; Elkady EF; Ayoub BM
Talanta; 2011 Jul; 85(1):673-80. PubMed ID: 21645757
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-assisted dispersive liquid-liquid microextraction for determination of three gliflozins in human plasma by HPLC/DAD.
Mabrouk MM; Soliman SM; El-Agizy HM; Mansour FR
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121932. PubMed ID: 31855838
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of simple spectrophotometric and chemometric methods for simultaneous determination of empagliflozin and metformin: Applied to recently approved pharmaceutical formulation.
Ayoub BM
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Nov; 168():118-122. PubMed ID: 27288963
[TBL] [Abstract][Full Text] [Related]
18. Ecofriendly appraisal of stability-indicating high-performance chromatographic assay of canagliflozin and metformin with their toxic impurities; in silico toxicity prediction.
Emam RA; Emam AA
J Sep Sci; 2023 Feb; 46(4):e2200754. PubMed ID: 36567309
[TBL] [Abstract][Full Text] [Related]
19. Stability-indicating HPLC method development and validation for simultaneous estimation of metformin, dapagliflozin, and saxagliptin in bulk drug and pharmaceutical dosage form.
Vankalapati KR; Alegete P; Boodida S
Biomed Chromatogr; 2022 Jul; 36(7):e5384. PubMed ID: 35434817
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of potential genotoxic impurities in metformin hydrochloride and empagliflozin tablets through ultra-performance liquid chromatographymass spectrometry.
Xiao T; Hu X; Chen Y; Lin H
J Pharm Biomed Anal; 2024 Apr; 241():116000. PubMed ID: 38280234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
